Monoclonal Mouse anti‑Human KRT2 / CK2 / Cytokeratin 2 Antibody (clone Ks2.398.3.1, IHC, WB) LS‑C193404
Monoclonal Mouse anti‑Human KRT2 / CK2 / Cytokeratin 2 Antibody (clone Ks2.398.3.1, IHC, WB) LS‑C193404
Antibody:
KRT2 / CK2 / Cytokeratin 2 Mouse anti-Human Monoclonal (Ks2.398.3.1) Antibody
Format:
Unconjugated, Unmodified
Overview
Antibody:
KRT2 / CK2 / Cytokeratin 2 Mouse anti-Human Monoclonal (Ks2.398.3.1) Antibody
Format:
Unconjugated, Unmodified
Specifications
Description
Cytokeratin 2 antibody LS-C193404 is an unconjugated mouse monoclonal antibody to human Cytokeratin 2 (KRT2 / CK2). Validated for IHC and WB.
Target
Human KRT2 / CK2 / Cytokeratin 2
Synonyms
KRT2 | Cytokeratin-2e | CK-2e | Epithelial keratin-2e | K2e | Keratin 2 | Keratin-2e | Krt2e | KRT2A | KRTE | Keratin-2 epidermis | Type-II keratin Kb2
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Unconjugated
Specificity
Human Keratin K2
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Presentation
0.09% Sodium Azide
Storage
Short term: store at 4°C. Long term: aliquot and store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About KRT2 / CK2 / Cytokeratin 2
Featured Products
Species:
Human, Mouse, Bovine
Applications:
IHC, Western blot
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Human, Chimpanzee, Monkey, Rat, Bovine, Dog
Applications:
IHC, IHC - Paraffin, Western blot
Reactivity:
Human
Range:
0.156-10 ng/ml
Source:
E. coli
Tag:
His-T7
Reactivity:
Rat
Range:
0.312-20 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/28/2024